Abstract

Background

Coronary artery calcification (CAC) can be detected by cardiac computed tomography (CT), is associated to cardiovascular risk, and common in asymptomatic individuals and patients referred for cardiac CT.

Design

CAC was evaluated in asymptomatic individuals and symptomatic patients referred for cardiac CT, to assess whether differences in CAC may be explained by symptoms or traditional cardiovascular risk factors.

Methods

The presence and extent of CAC, gender, family history of coronary artery disease, hypertension, hyperlipidaemia, diabetes and tobacco were compared in 1220 asymptomatic individuals aged 49–61 years and 2257 age-matched symptomatic patients referred for cardiac CT with suspected coronary artery disease.

Results

Symptomatic individuals had a higher frequency of a family history of coronary artery disease (46% vs. 23%, p < 0.001), hypertension (38% vs. 21%, p < 0.001), hyperlipidaemia (42% vs. 12%, p < 0.001), a trend for more diabetes (6% vs. 5%, p = 0.05), but no significant difference was observed for the presence of CAC (Agatston > 0; 45% vs. 45%, p = 0.94) or severe calcifications (Agatston > 400; 6% vs. 5%, p = 0.36). In multivariate analyses age (odds ratio (OR) 1.09–1.18), male gender (OR 3.5–6.43), hypertension (OR 1.42–1.79), hyperlipidaemia (OR 1.86–2.09) and tobacco use (OR 1.83–2.01) were predictors for the presence and extent of CAC, whereas symptoms were not predictive for the presence of (Agatston > 0, OR 0.70 (0.59–0.83)), mild (Agatston ≥ 10; OR 0.85 (0.71–1.02)), moderate (Agatston ≥ 100; OR 0.99 (0.79–1.24)) or severe calcifications (Agatston ≥ 400; OR 0.93 (0.65–1.33)).

Conclusion

No difference in the presence or severity of coronary calcifications was observed between asymptomatic and symptomatic middle-aged individuals. After adjusting for cardiovascular risk factors, symptoms were not predictive for the presence or extent of CAC.

Introduction

Coronary artery calcification (CAC) as assessed by cardiac computed tomography (CT) has been extensively evaluated.14 In asymptomatic and symptomatic individuals the extent of CAC is associated with increased risk of cardiovascular events and death, whereas the absence of CAC portends a favourable prognosis.4,5 Furthermore, CAC provides incremental prognostic value in addition to traditional risk factors.613 Although the mortality related to coronary artery disease (CAD) has declined in western countries during the last years, cardiovascular diseases still constitute a major public health problem worldwide.14,15

While coronary calcifications in asymptomatic individuals and in patients referred for cardiac CT are quite common, a comparison of these groups taking traditional cardiovascular risk factors into account has not previously been thoroughly evaluated. Thus, we investigated the presence and severity of CAC in asymptomatic individuals and patients referred for cardiac CT with symptoms suggestive of CAD, to evaluate whether any potential difference in coronary calcification may be explained by the presence of symptoms or by traditional cardiovascular risk factors.

Methods

Study cohorts

A random selected sample of 1825 men and women aged 50 and 60 years living in the southern part of Denmark was invited to participate in a cardiovascular screening programme with evaluation of medical history, assessment of cardiovascular risk factors and CAC scanning in 2009 as previously described.3 From this cohort 1220 individuals without symptoms or a history of cardiovascular disease (i.e. stroke, myocardial infarction, percutaneous coronary intervention or coronary artery bypass surgery) underwent a CAC scan. The protocol was approved by the regional scientific ethical committee (S-20080140) and conducted according to the Declaration of Helsinki. All participants gave written informed consent. From the same geographical area prospectively entered data on cardiovascular risk factors and CAC were retrieved from a clinical database with patients undergoing cardiac CT due to symptoms suggestive of CAD. Participating imaging centres use similar guidelines for referral to cardiac CT in patients with symptoms suggestive of and without previous history of CAD: low-to-intermediate pre-test likelihood of CAD, regular heartbeat, and normal or near normal renal function.16 From 2009 to 2013 complete data on 2257 symptomatic patients referred for cardiac CT for clinical reasons with stable suspected and not known history of CAD aged 50–60 years were included for comparative analyses.

A family history of CAD was defined as any first-degree male or female relative with CAD before the age of 55 or 65 years old, respectively. Hypertension was defined as use of anti-hypertensive medication(s) or blood pressure ≥140/90 mmHg. Hyperlipidaemia was defined as use of lipid lowering medication(s) or total cholesterol ≥5 mmol/l. Diabetes mellitus was defined as use of anti-diabetic medication(s) or fasting glucose ≥7.0 mmol/l. Tobacco use was defined as current use of tobacco.

Cardiac CT

Coronary calcium scans were acquired during inspiratory breath hold as non-contrast enhanced prospective ECG-gated scans triggered at 50–75% of R-R interval, using 2.5 or 3.0 mm collimation with gantry rotation time 330–500 ms, tube current 150–200 mA and tube voltage of 120 kV. CAC was assessed using the Agatston (Ag) score.17

Statistical analyses

Cardiovascular risk factors including age, gender, family history of CAD, hypertension, hyperlipidaemia, diabetes mellitus, tobacco use and Ag scores are presented as frequencies, mean (±standard deviation) and median (range) as appropriate. Comparisons between groups were performed using Fisher’s exact test and Mann–Whitney U-test as appropriate. In a sub-analysis of patients with a detailed symptom description, Kruskal–Wallis rank test was used to evaluate any differences in Ag scores according to symptom classification as non-anginal, atypical and typical angina.18 In the univariate and multivariate analyses, symptoms were defined as present or absent. The presence of symptoms and cardiovascular risk factors were evaluated in univariate and multivariate logistic regression analyses as predictors for the presence (Ag > 0) and extent of coronary calcification (Ag ≥ 10, ≥100, and ≥400) with multiple analyses per CAC level. Regression analyses are presented as odds ratios (ORs) with 95% confidence intervals (CIs). All tests were two-tailed using a significance level of 5%. Analyses were performed using STATA 10.0 (StataCorp, Texas, USA).

Results

In the cohort of 3477 individuals, no difference between asymptomatic (n = 1220) and symptomatic (n = 2257) individuals was observed in gender or tobacco use. Symptomatic individuals more frequently presented with a family history of CAD, hypertension, hyperlipidaemia and a trend towards more diabetes (Table 1). We observed a higher proportion of symptomatic patients with Ag ≥ 10 and ≥100, but no significant difference was observed for the presence of (Ag > 0) or severe coronary calcifications (Ag ≥ 400) (Table 1). A detailed symptom description was available in 709 of 2257 patients (31%), with 274 patients with non-anginal chest pain, 197 with atypical angina and 238 with typical angina. The median (interquartile range, range) Agatston score was: non-anginal chest pain 0 ((0; 26), 0–1081), atypical angina 0 ((0; 51), 0–6300), and typical angina 0 ((0; 31), 0–1504), without any significant difference between groups (p = 0.57).

Table 1.

Patient demographics.

Asymptomatic (n = 1220)Symptomatic (n = 2257)p-value
Age, years, mean ± SD55.3 ± 5.055.5 ± 3.40.49
Male gender (%)579 (47.5)1015 (45.0)0.16
Family history of CAD (%)284 (23.3)1048(46.4)<0.001
Hypertension (%)260 (21.3)861 (38.2)<0.001
Hyperlipidaemia (%)149 (12.2)938 (41.6)<0.001
Diabetes mellitus (%)57 (4.7)138 (6.1)0.05
Tobacco (%)309 (25.3)602 (26.7)0.49
Agatston > 0 (%)548 (44.9)1010 (44.7)0.94
Agatston ≥ 10 (%)396 (32.5)829 (36.7)0.01
Agatston ≥ 100 (%)181 (14.8)403 (17.9)0.03
Agatston ≥ 400 (%)64 (5.2)135 (6.0)0.36
Asymptomatic (n = 1220)Symptomatic (n = 2257)p-value
Age, years, mean ± SD55.3 ± 5.055.5 ± 3.40.49
Male gender (%)579 (47.5)1015 (45.0)0.16
Family history of CAD (%)284 (23.3)1048(46.4)<0.001
Hypertension (%)260 (21.3)861 (38.2)<0.001
Hyperlipidaemia (%)149 (12.2)938 (41.6)<0.001
Diabetes mellitus (%)57 (4.7)138 (6.1)0.05
Tobacco (%)309 (25.3)602 (26.7)0.49
Agatston > 0 (%)548 (44.9)1010 (44.7)0.94
Agatston ≥ 10 (%)396 (32.5)829 (36.7)0.01
Agatston ≥ 100 (%)181 (14.8)403 (17.9)0.03
Agatston ≥ 400 (%)64 (5.2)135 (6.0)0.36

CAD: coronary artery disease; SD: standard deviation.

Table 1.

Patient demographics.

Asymptomatic (n = 1220)Symptomatic (n = 2257)p-value
Age, years, mean ± SD55.3 ± 5.055.5 ± 3.40.49
Male gender (%)579 (47.5)1015 (45.0)0.16
Family history of CAD (%)284 (23.3)1048(46.4)<0.001
Hypertension (%)260 (21.3)861 (38.2)<0.001
Hyperlipidaemia (%)149 (12.2)938 (41.6)<0.001
Diabetes mellitus (%)57 (4.7)138 (6.1)0.05
Tobacco (%)309 (25.3)602 (26.7)0.49
Agatston > 0 (%)548 (44.9)1010 (44.7)0.94
Agatston ≥ 10 (%)396 (32.5)829 (36.7)0.01
Agatston ≥ 100 (%)181 (14.8)403 (17.9)0.03
Agatston ≥ 400 (%)64 (5.2)135 (6.0)0.36
Asymptomatic (n = 1220)Symptomatic (n = 2257)p-value
Age, years, mean ± SD55.3 ± 5.055.5 ± 3.40.49
Male gender (%)579 (47.5)1015 (45.0)0.16
Family history of CAD (%)284 (23.3)1048(46.4)<0.001
Hypertension (%)260 (21.3)861 (38.2)<0.001
Hyperlipidaemia (%)149 (12.2)938 (41.6)<0.001
Diabetes mellitus (%)57 (4.7)138 (6.1)0.05
Tobacco (%)309 (25.3)602 (26.7)0.49
Agatston > 0 (%)548 (44.9)1010 (44.7)0.94
Agatston ≥ 10 (%)396 (32.5)829 (36.7)0.01
Agatston ≥ 100 (%)181 (14.8)403 (17.9)0.03
Agatston ≥ 400 (%)64 (5.2)135 (6.0)0.36

CAD: coronary artery disease; SD: standard deviation.

Univariate and multivariate analyses

In univariate and multivariate analyses age, male gender, hypertension, hyperlipidaemia and tobacco use were associated with Ag > 0, ≥10, ≥100 and ≥400 (Tables 2 and 3). In univariate analyses symptoms were associated with Ag ≥ 10 and Ag ≥ 100, however, after adjusting for cardiovascular risk factors symptoms were not associated with Ag ≥ 10, ≥100, or ≥400, and in fact inversely related to the presence of CAC (Ag > 0). There was a significant relation between Ag > 0, Ag > 10, Ag > 100, Ag > 400 (Table 2) and the numbers of risk factors. We found a significant relation between coronary calcification and the numbers of risk factors for both asymptomatic individuals and symptomatic patients (p < 0.001 for both).

Table 2.

Univariate analyses for prediction of coronary calcification.

Ag > 0, OR (95% CI)Ag ≥ 10, OR (95% CI)Ag ≥ 100, OR (95% CI)Ag ≥ 400, OR (95% CI)
Symptoms0.99 (0.86–1.14)1.21 (1.03–1.40)1.25 (1.03–1.51)1.18 (0.87–1.60)
Age, per year1.08 (1.06–1.10)1.09 (1.07–1.11)1.12 (1.09–1.14)1.16 (1.11–1.20)
Male gender3.19 (2.77–3.67)2.92 (2.53–3.37)3.98 (3.27–4.85)5.21 (3.66–7.42)
Family history of CAD1.25 (1.09–1.44)1.30 (1.13–1.50)1.00 (0.83–1.21)1.20 (0.89–1.60)
Hypertension1.54 (1.33–1.77)1.82 (1.57–2.11)1.94 (1.62–2.33)1.93 (1.45–2.58)
Hyperlipidaemia1.98 (1.71–2.29)2.28 (1.96–2.64)2.11 (1.76–2.53)2.32 (1.74–3.09)
Diabetes2.11 (1.57–2.84)2.27 (1.69–3.03)1.95 (1.40–2.70)1.61 (0.96–2.70)
Tobacco1.74 (1.50–2.03)1.86 (1.59–2.17)1.74 (1.44–2.10)1.80 (1.34–2.42)
No. of risk factorsa1.36 (1.29–1.44)1.43 (1.35–1.51)1.41 (1.32–1.52)1.53 (1.37–1.70)
Ag > 0, OR (95% CI)Ag ≥ 10, OR (95% CI)Ag ≥ 100, OR (95% CI)Ag ≥ 400, OR (95% CI)
Symptoms0.99 (0.86–1.14)1.21 (1.03–1.40)1.25 (1.03–1.51)1.18 (0.87–1.60)
Age, per year1.08 (1.06–1.10)1.09 (1.07–1.11)1.12 (1.09–1.14)1.16 (1.11–1.20)
Male gender3.19 (2.77–3.67)2.92 (2.53–3.37)3.98 (3.27–4.85)5.21 (3.66–7.42)
Family history of CAD1.25 (1.09–1.44)1.30 (1.13–1.50)1.00 (0.83–1.21)1.20 (0.89–1.60)
Hypertension1.54 (1.33–1.77)1.82 (1.57–2.11)1.94 (1.62–2.33)1.93 (1.45–2.58)
Hyperlipidaemia1.98 (1.71–2.29)2.28 (1.96–2.64)2.11 (1.76–2.53)2.32 (1.74–3.09)
Diabetes2.11 (1.57–2.84)2.27 (1.69–3.03)1.95 (1.40–2.70)1.61 (0.96–2.70)
Tobacco1.74 (1.50–2.03)1.86 (1.59–2.17)1.74 (1.44–2.10)1.80 (1.34–2.42)
No. of risk factorsa1.36 (1.29–1.44)1.43 (1.35–1.51)1.41 (1.32–1.52)1.53 (1.37–1.70)

Ag: Agatston; CAD: coronary artery disease; OR: odds ratio; CI: confidence interval.

a

Risk factors included: age > 57 years (50th percentile), male gender, family history of CAD, hypertension, hyperlipidaemia, diabetes and tobacco use.

Table 2.

Univariate analyses for prediction of coronary calcification.

Ag > 0, OR (95% CI)Ag ≥ 10, OR (95% CI)Ag ≥ 100, OR (95% CI)Ag ≥ 400, OR (95% CI)
Symptoms0.99 (0.86–1.14)1.21 (1.03–1.40)1.25 (1.03–1.51)1.18 (0.87–1.60)
Age, per year1.08 (1.06–1.10)1.09 (1.07–1.11)1.12 (1.09–1.14)1.16 (1.11–1.20)
Male gender3.19 (2.77–3.67)2.92 (2.53–3.37)3.98 (3.27–4.85)5.21 (3.66–7.42)
Family history of CAD1.25 (1.09–1.44)1.30 (1.13–1.50)1.00 (0.83–1.21)1.20 (0.89–1.60)
Hypertension1.54 (1.33–1.77)1.82 (1.57–2.11)1.94 (1.62–2.33)1.93 (1.45–2.58)
Hyperlipidaemia1.98 (1.71–2.29)2.28 (1.96–2.64)2.11 (1.76–2.53)2.32 (1.74–3.09)
Diabetes2.11 (1.57–2.84)2.27 (1.69–3.03)1.95 (1.40–2.70)1.61 (0.96–2.70)
Tobacco1.74 (1.50–2.03)1.86 (1.59–2.17)1.74 (1.44–2.10)1.80 (1.34–2.42)
No. of risk factorsa1.36 (1.29–1.44)1.43 (1.35–1.51)1.41 (1.32–1.52)1.53 (1.37–1.70)
Ag > 0, OR (95% CI)Ag ≥ 10, OR (95% CI)Ag ≥ 100, OR (95% CI)Ag ≥ 400, OR (95% CI)
Symptoms0.99 (0.86–1.14)1.21 (1.03–1.40)1.25 (1.03–1.51)1.18 (0.87–1.60)
Age, per year1.08 (1.06–1.10)1.09 (1.07–1.11)1.12 (1.09–1.14)1.16 (1.11–1.20)
Male gender3.19 (2.77–3.67)2.92 (2.53–3.37)3.98 (3.27–4.85)5.21 (3.66–7.42)
Family history of CAD1.25 (1.09–1.44)1.30 (1.13–1.50)1.00 (0.83–1.21)1.20 (0.89–1.60)
Hypertension1.54 (1.33–1.77)1.82 (1.57–2.11)1.94 (1.62–2.33)1.93 (1.45–2.58)
Hyperlipidaemia1.98 (1.71–2.29)2.28 (1.96–2.64)2.11 (1.76–2.53)2.32 (1.74–3.09)
Diabetes2.11 (1.57–2.84)2.27 (1.69–3.03)1.95 (1.40–2.70)1.61 (0.96–2.70)
Tobacco1.74 (1.50–2.03)1.86 (1.59–2.17)1.74 (1.44–2.10)1.80 (1.34–2.42)
No. of risk factorsa1.36 (1.29–1.44)1.43 (1.35–1.51)1.41 (1.32–1.52)1.53 (1.37–1.70)

Ag: Agatston; CAD: coronary artery disease; OR: odds ratio; CI: confidence interval.

a

Risk factors included: age > 57 years (50th percentile), male gender, family history of CAD, hypertension, hyperlipidaemia, diabetes and tobacco use.

Table 3.

Multivariate analyses for prediction of coronary calcification.

Ag > 0, OR (95% CI)Ag ≥ 10, OR (95% CI)Ag ≥ 100, OR (95% CI)Ag ≥ 400, OR (95% CI)
Symptoms0.70 (0.59–0.83)0.85 (0.71–1.02)0.99 (0.79–1.24)0.93 (0.65–1.33)
Age, per year1.09 (1.07–1.11)1.11 (1.09–1.13)1.13 (1.10–1.16)1.18 (1.12–1.23)
Male gender3.76 (3.22–4.38)3.50 (2.98–4.11)4.90 (3.95–6.08)6.43 (4.41–9.40)
Family history of CAD1.43 (1.22–1.68)1.37 (1.16–1.62)1.02 (0.83–1.26)1.25 (0.91–1.73)
Hypertension1.42 (1.20–1.68)1.62 (1.37–1.92)1.79 (1.45–2.22)1.71 (1.23–2.36)
Hyperlipidaemia1.86 (1.56–2.22)1.98 (1.66–2.37)1.87 (1.50–2.34)2.09 (1.49–2.95)
Diabetes1.34 (0.96–1.87)1.41 (1.01–1.96)1.10 (0.76–1.61)0.91 (0.52–1.60)
Tobacco1.83 (1.55–2.17)2.01 (1.69–2.38)1.90 (1.54–2.35)1.86 (1.35–2.56)
Ag > 0, OR (95% CI)Ag ≥ 10, OR (95% CI)Ag ≥ 100, OR (95% CI)Ag ≥ 400, OR (95% CI)
Symptoms0.70 (0.59–0.83)0.85 (0.71–1.02)0.99 (0.79–1.24)0.93 (0.65–1.33)
Age, per year1.09 (1.07–1.11)1.11 (1.09–1.13)1.13 (1.10–1.16)1.18 (1.12–1.23)
Male gender3.76 (3.22–4.38)3.50 (2.98–4.11)4.90 (3.95–6.08)6.43 (4.41–9.40)
Family history of CAD1.43 (1.22–1.68)1.37 (1.16–1.62)1.02 (0.83–1.26)1.25 (0.91–1.73)
Hypertension1.42 (1.20–1.68)1.62 (1.37–1.92)1.79 (1.45–2.22)1.71 (1.23–2.36)
Hyperlipidaemia1.86 (1.56–2.22)1.98 (1.66–2.37)1.87 (1.50–2.34)2.09 (1.49–2.95)
Diabetes1.34 (0.96–1.87)1.41 (1.01–1.96)1.10 (0.76–1.61)0.91 (0.52–1.60)
Tobacco1.83 (1.55–2.17)2.01 (1.69–2.38)1.90 (1.54–2.35)1.86 (1.35–2.56)

Ag: Agatston; CAD: coronary artery disease; OR: odds ratio; CI: confidence interval.

Table 3.

Multivariate analyses for prediction of coronary calcification.

Ag > 0, OR (95% CI)Ag ≥ 10, OR (95% CI)Ag ≥ 100, OR (95% CI)Ag ≥ 400, OR (95% CI)
Symptoms0.70 (0.59–0.83)0.85 (0.71–1.02)0.99 (0.79–1.24)0.93 (0.65–1.33)
Age, per year1.09 (1.07–1.11)1.11 (1.09–1.13)1.13 (1.10–1.16)1.18 (1.12–1.23)
Male gender3.76 (3.22–4.38)3.50 (2.98–4.11)4.90 (3.95–6.08)6.43 (4.41–9.40)
Family history of CAD1.43 (1.22–1.68)1.37 (1.16–1.62)1.02 (0.83–1.26)1.25 (0.91–1.73)
Hypertension1.42 (1.20–1.68)1.62 (1.37–1.92)1.79 (1.45–2.22)1.71 (1.23–2.36)
Hyperlipidaemia1.86 (1.56–2.22)1.98 (1.66–2.37)1.87 (1.50–2.34)2.09 (1.49–2.95)
Diabetes1.34 (0.96–1.87)1.41 (1.01–1.96)1.10 (0.76–1.61)0.91 (0.52–1.60)
Tobacco1.83 (1.55–2.17)2.01 (1.69–2.38)1.90 (1.54–2.35)1.86 (1.35–2.56)
Ag > 0, OR (95% CI)Ag ≥ 10, OR (95% CI)Ag ≥ 100, OR (95% CI)Ag ≥ 400, OR (95% CI)
Symptoms0.70 (0.59–0.83)0.85 (0.71–1.02)0.99 (0.79–1.24)0.93 (0.65–1.33)
Age, per year1.09 (1.07–1.11)1.11 (1.09–1.13)1.13 (1.10–1.16)1.18 (1.12–1.23)
Male gender3.76 (3.22–4.38)3.50 (2.98–4.11)4.90 (3.95–6.08)6.43 (4.41–9.40)
Family history of CAD1.43 (1.22–1.68)1.37 (1.16–1.62)1.02 (0.83–1.26)1.25 (0.91–1.73)
Hypertension1.42 (1.20–1.68)1.62 (1.37–1.92)1.79 (1.45–2.22)1.71 (1.23–2.36)
Hyperlipidaemia1.86 (1.56–2.22)1.98 (1.66–2.37)1.87 (1.50–2.34)2.09 (1.49–2.95)
Diabetes1.34 (0.96–1.87)1.41 (1.01–1.96)1.10 (0.76–1.61)0.91 (0.52–1.60)
Tobacco1.83 (1.55–2.17)2.01 (1.69–2.38)1.90 (1.54–2.35)1.86 (1.35–2.56)

Ag: Agatston; CAD: coronary artery disease; OR: odds ratio; CI: confidence interval.

Discussion

The major findings in the present study are: 1) the proportions of individuals with any coronary calcification (Ag > 0) or severe coronary calcification (Ag ≥ 400) are similar in middle-aged, randomly selected, asymptomatic individuals compared with patients referred for cardiac CT with symptoms suggestive of CAD, and 2) no clear association between symptoms and the presence or severity of CAC in middle-aged men and women.

Not surprisingly, traditional cardiovascular risk factors including age, male gender, hypertension, hyperlipideamia, tobacco use, and the number of risk factors were all associated with the presence and severity of CAC. In fact, age and male gender were the most powerful predictors of any level of CAC with ORs ranging from 2.4 to 5.2 per 10 years of age and from 3.5 to 6.4 for male gender. After adjusting for the traditional cardiovascular risk factors, symptoms were not related to Ag ≥ 10, ≥100 or ≥400, and in fact inversely related to the presence of CAC (Ag > 0). Furthermore, there was no relation between symptom severity and CAC in the sub-group of patients where a detailed symptom description was available. These observations underline the impact of traditional cardiovascular risk factors for the development of atherosclerosis and as predictors for coronary calcification. A possible explanation for the apparent inverse relation between symptoms and the presence of CAC (Ag > 0), may be the left skewed distribution of CAC (most individuals had no CAC) combined with a likely more rigorous analysis of the presence or absence of small amounts of calcification in a scientific study versus a clinical setting.19

The absence of significant difference in the proportion of patients with at least mild (Ag ≥ 10), moderate (Ag ≥ 100) or severe (Ag ≥ 400) calcifications in asymptomatic and symptomatic middle-aged men and women is intriguing. Approximately half of the asymptomatic middle-aged men and women have subclinical atherosclerosis. This observation is well established and may be of public health concern; however, its clinical implication in relation to treatment remains unsolved.2,3 Limited scientific evidence and no clear recommendations are available as to whether these individuals should or would benefit from medical preventive treatment or intensive risk factor handling.16,20 Furthermore, middle-aged patients with suspected CAD who are evaluated with a cardiac CT scan have no more CAC than age-matched supposedly healthy volunteers. This is surprising since these individuals would intuitively be expected to have more atherosclerosis, thus more coronary artery disease, causing symptoms (angina). Potential explanations for this finding may be that the atherosclerotic plaque causing symptoms is either not calcified, or that the symptoms leading the patients to cardiac CT scan are of non-coronary origin. In favour of the latter interpretation is the fact that the selection of patients for cardiac CT according to current guidelines is based on age, sex and symptoms, recommending cardiac CT primarily for patients with low intermediate (15–50%) pre-test likelihood of significant CAD.16 An evaluation of CAC in relation to coronary CTA may provide valuable information. Although the absence of CAC (approximately half of the symptomatic patients in the present study) does not exclude coronary stenosis or obviates the need for further evaluation,21 a decrease in diagnostic specificity of coronary CTA combined with an increased prevalence of significant stenosis in patients with an Ag score >400 makes it reasonable not to proceed with the coronary CTA as outlined in the recent European Guidelines.16

Coronary calcification is not only a sign of coronary atherosclerosis, but also an indicator of the total coronary atherosclerotic plaque burden.22 Indeed, coronary calcification has an incremental prognostic value when added to cardiovascular risk factors,4,68,12,13,23 and a graded relation between coronary atherosclerosis and cardiovascular risk has been established.11,2426 Hypertension, hyperlipidaemia and tobacco are modifiable risk factors and thus amenable to primary and secondary prevention; however, the risk factors most strongly associated (age and gender) with coronary calcifications are unfortunately not amenable to cardiovascular risk prevention. It would thus make sense to include an assessment of coronary calcification in order to improve risk stratification, to possibly identify patients where a more rigorous risk factor handling or even medical preventive therapy could be valuable. A total risk estimation using multiple risk factors (such as SCORE) is recommended for asymptomatic adults without evidence of cardiovascular disease.27 The majority (78%) of the asymptomatic individuals in the present study were as previously reported at low (<5%) 10-year risk of a fatal cardiovascular disease event.3 Furthermore, 37% of individuals with >5% 10-year risk of fatal event were as previously reported without any signs of coronary calcifications.3 Whether these findings warrant up-grade or down-grade in overall risk assessment, and should have implications for primary risk prevention including medical therapy, remains unclear and warrants further investigations.

Limitations

This is a retrospectively designed observational cohort study. We did not have a detailed symptom description in all patients and any inference considering the relation between symptom severity and coronary calcification should be made with caution. It should be recognized that the symptomatic patients included in the present analyses represent the core of patients referred for cardiac CT, and the association of cardiovascular risk factors and symptoms may be different in patients with more severe CAD. Furthermore, data on the presence of angiographic stenosis was not available. Patients with a coronary stenosis would be expected to have a larger extent of coronary calcification,28 thus, excluding these patients would not only introduce a selection bias, but is also unlikely to enforce an association of symptoms and CAC. Finally, at this stage, follow-up data cannot be provided to evaluate whether coronary calcifications have different prognostic significance in asymptomatic and symptomatic individuals.

Conclusion

In middle-aged men and women, coronary calcification is common, and primarily related to age and male gender followed by hypertension, hyperlipidaemia and tobacco use. In middle-aged patients referred for cardiac CT with symptoms suggestive of CAD, age, male gender, hypertension, hyperlipidaemia and tobacco use, but not symptoms, were associated with the presence or extent of coronary calcification.

Funding

The Danrisk study was supported by Region Syddanmark (grant number 08-17862) and Odense University Hospital, Denmark.

Conflict of interest

The authors declare that there is no conflict of interest.

References

1

Lamonte
MJ
,
Fitzgerald
SJ
,
Church
TS
et al. .
Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women
.
Am J Epidemiol
 
2005
;
162
:
421
429
.

2

Erbel
R
,
Delaney
JA
,
Lehmann
N
et al. .
Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR)
.
Eur Heart J
 
2008
;
29
:
2782
2791
.

3

Diederichsen
AC
,
Sand
NP
,
Norgaard
B
et al. .
Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: The DanRisk study
.
Eur J Prev Cardiol
 
2012
;
19
:
558
564
.

4

Detrano
R
,
Guerci
AD
,
Carr
JJ
et al. .
Coronary calcium as a predictor of coronary events in four racial or ethnic groups
.
N Engl J Med
 
2008
;
358
:
1336
1345
.

5

Sarwar
A
,
Shaw
LJ
,
Shapiro
MD
et al. .
Diagnostic and prognostic value of absence of coronary artery calcification
.
JACC Cardiovasc Imaging
 
2009
;
2
:
675
688
.

6

Erbel
R
,
Mohlenkamp
S
,
Moebus
S
et al. .
Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: The Heinz Nixdorf Recall study
.
J Am Coll Cardiol
 
2010
;
56
:
1397
1406
.

7

Hadamitzky M, Distler R, Meyer T, et al. Prognostic value of coronary computed tomographic angiography in comparison with calcium scoring and clinical risk scores. Circ Cardiovasc Imaging 2011; 4(1): 16–23
.

8

Polonsky
TS
,
McClelland
RL
,
Jorgensen
NW
et al. .
Coronary artery calcium score and risk classification for coronary heart disease prediction
.
JAMA
 
2010
;
303
:
1610
1616
.

9

Budoff
MJ
,
Nasir
K
,
McClelland
RL
et al. .
Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis)
.
J Am Coll Cardiol
 
2009
;
53
:
345
352
.

10

Nucifora G, Bax JJ, van Werkhoven JM, et al. Coronary artery calcium scoring in cardiovascular risk assessment. Cardiovasc Ther Cardiovasc Ther 2011; 29(6): e43–e53
.

11

Greenland
P
,
LaBree
L
,
Azen
SP
et al. .
Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals
.
JAMA
 
2004
;
291
:
210
215
.

12

Kara
K
,
Mahabadi
AA
,
Berg
MH
et al. .
Predicting risk of coronary events and all-cause mortality: Role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: The Heinz Nixdorf Recall Study
.
Eur J Prev Cardiol
 
2014
;
21
:
1171
1179
.

13

Yeboah
J
,
Carr
JJ
,
Terry
JG
et al. .
Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: The Multi-Ethnic Study of Atherosclerosis
.
Eur J Prev Cardiol
 
2014
;
21
:
1233
1241
.

14

Roger
VL
,
Go
AS
,
Lloyd-Jones
DM
et al. .
Heart disease and stroke statistics – 2011 update: A Report From the American Heart Association
.
Circulation
 
2011
;
123
:
e18
e209
.

15

World Health Organization. The top 10 causes of death (2000 and 2012), http://www.who.int/mediacentre/factsheets/fs310/en/index.html (accessed 6 February 2011)
.

16

Montalescot
G
,
Sechtem
U
,
Achenbach
S
et al. .
2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology
.
Eur Heart J
 
2013
;
34
:
2949
3003
.

17

Agatston
AS
,
Janowitz
WR
,
Hildner
FJ
et al. .
Quantification of coronary artery calcium using ultrafast computed tomography
.
J Am Coll Cardiol
 
1990
;
15
:
827
832
.

18

Diamond
GA
.
A clinically relevant classification of chest discomfort
.
J Am Coll Cardiol
 
1983
;
1
:
574
575
.

19

Jain
T
,
Peshock
R
,
McGuire
DK
et al. .
African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study
.
J Am Coll Cardiol
 
2004
;
44
:
1011
1017
.

20

Miedema
MD
,
Duprez
DA
,
Misialek
JR
et al. .
Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: Estimates from the multi-ethnic study of atherosclerosis
.
Circ Cardiovasc Qual Outcomes
 
2014
;
7
:
453
460
.

21

Marwan
M
,
Ropers
D
,
Pflederer
T
et al. .
Clinical characteristics of patients with obstructive coronary lesions in the absence of coronary calcification: An evaluation by coronary CT angiography
.
Heart
 
2009
;
95
:
1056
1060
.

22

Rumberger
JA
,
Simons
DB
,
Fitzpatrick
LA
et al. .
Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study
.
Circulation
 
1995
;
92
:
2157
2162
.

23

Al-Mallah MH, Qureshi W, Lin FY, et al. Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry. Eur Heart J Cardiovasc Imaging 2013; 15(3): 267–274
.

24

Mahabadi
AA
,
Mohlenkamp
S
,
Moebus
S
et al. .
The Heinz Nixdorf Recall study and its potential impact on the adoption of atherosclerosis imaging in European primary prevention guidelines
.
Curr Atheroscler Rep
 
2011
;
13
:
367
372
.

25

Shaw
LJ
,
Berman
DS
,
Hendel
RC
et al. .
Prognosis by coronary computed tomographic angiography: Matched comparison with myocardial perfusion single-photon emission computed tomography
.
J Cardiovasc Comput Tomogr
 
2008
;
2
:
93
101
.

26

Hulten EA, Carbonaro S, Petrillo SP, et al. Prognostic Value of cardiac computed tomography angiography a systematic review and meta-analysis. J Am Coll Cardiol 2011; 57(10): 1237–1247
.

27

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
.
The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
.
Eur J Prev Cardiol
 
2012
;
19
:
585
667
.

28

Villines
TC
,
Hulten
EA
,
Shaw
LJ
et al. .
Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: Results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry
.
J Am Coll Cardiol
 
2011
;
58
:
2533
2540
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.